| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.44 | 0.008 |